Cari Gallman Exercises Options at Bristol Myers Squibb Co (BMY) — SEC Form 4, Aug 04, 2026
SEC Form 4 · No Market Transaction
Option Exercise
Derivative exercise — no open market transaction.
Equity Position
14.2K sh
13,674 → 14,192
Equity Change
+3.8%
shares held after vs before
Filing Lag
2 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Cari Gallman CIK 0001995058 |
GC
|
Cari Gallman at Bristol Myers Squibb Co
Full insider history
Bought (12 mo)
—
Sold (12 mo)
—
More from this insider at Bristol Myers Squibb Co
| 2026-10-05 | Exercise | — | View |
| 2026-03-12 | Exercise | — | View |
| 2025-10-06 | Exercise | — | View |
| 2025-08-05 | Exercise | — | View |
| 2025-03-13 | Exercise | — | View |
Non-Derivative Securities Transactions
Derivative Securities Transactions
Footnotes (3)
Related filings at Bristol Myers Squibb Co
Institutional Holders
13F holders · Jun 30, 2026
2,539
institutional managers reporting a position
Largest by reported value
- Black Rock, Inc. $10.4B
- Vanguard Capital Management Llc $7.68B
- State Street Corporation $5.9B
5%+ Holders · 13D/G
3 filers
Other insiders at Bristol Myers Squibb Co
GET /v1/forms/4/0001995058-26-000005
API docs
View Original SEC Filing